Citigroup’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,605
Closed -$2.46K 5807
2023
Q2
$2.46K Sell
3,605
-100
-3% -$85 ﹤0.01% 5262
2023
Q1
$4.08K Sell
3,705
-3,500
-49% -$2.29K ﹤0.01% 4986
2022
Q4
$4.35K Sell
7,205
-21,610
-75% -$14.3K ﹤0.01% 5066
2022
Q3
$22K Buy
28,815
+25,738
+836% +$19.4K ﹤0.01% 4719
2022
Q2
$2K Sell
3,077
-246,923
-99% -$212K ﹤0.01% 5922
2022
Q1
$263K Hold
250,000
﹤0.01% 3912
2021
Q4
$240K Buy
+250,000
New +$331K ﹤0.01% 4256

Other funds holding TLSA

Citigroup's TLSA Position: Q3 2023 in Review

Citigroup sold out of Tiziana Life Sciences (TLSA) in Q3 2023, closing a stake of 3,605 shares — an estimated $2.46K sold.

Citigroup first reported a position in TLSA in Q4 2021 and held it in 7 quarters. The position peaked at $263K in Q1 2022. 24 funds tracked by Wall St. Rank hold TLSA as of Q3 2023.

  • Citigroup reported no remaining Tiziana Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Citigroup sold 3,605 Tiziana Life Sciences shares in Q3 2023, an estimated $2.46K.
  • Citigroup first reported a position in Tiziana Life Sciences in Q4 2021 and held it in 7 quarters.
  • Citigroup's Tiziana Life Sciences position peaked at $263K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q3 2023.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.